![Dennis D. Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dennis D. Kim
Amministratore Delegato presso
Xeno Biosciences, Inc.
Profilo
Dennis D.
Kim is President & Chief Executive Officer at Xeno Biosciences, Inc. Former positions include Executive Director-Strategy at Amylin Pharmaceuticals, Inc. from 2001 to 2007; Independent Director at Inversago Pharma, Inc. from 2019 to 2022; Chief Medical Officer at CymaBay Therapeutics, Inc. from 2021 to 2023; Senior VP-Medical Affairs & Communications at Orexigen Therapeutics, Inc. from 2010 to 2011; Chief Medical Officer at Zafgen, Inc. from 2011 to 2019; Chief Medical Officer at Cebix, Inc.; Assistant Professor at the University of California San Diego from 2001 to 2012; Chief Medical Officer & VP-Medical Affairs at EnteroMedics, Inc. from 2007 to 2008; Chief Medical Officer at Skye Bioscience, Inc. from 2019 to 2020; Chief Medical Officer at Emerald Health Sciences, Inc.; and Chief Medical Officer at AFYX Therapeutics AS.
Education includes a doctorate from Finch University of Health Sciences, an undergraduate degree from the University of California, Los Angeles, an MBA from Rady School of Management at UC San Diego, and a doctorate from Chicago Medical School.
Posizioni attive di Dennis D. Kim
| Società | Posizione | Inizio |
|---|---|---|
Xeno Biosciences, Inc.
 Xeno Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company pioneering a novel class of treatments for metabolic diseases | Amministratore Delegato | - |
Precedenti posizioni note di Dennis D. Kim
| Società | Posizione | Fine |
|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 20/02/2023 |
Inversago Pharma, Inc.
 Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops CB1 receptor based therapies for obesity, diabetes and complication treatment | Direttore/Membro del Consiglio | 19/10/2022 |
| SKYE BIOSCIENCE, INC. | Direttore Tecnico/Scientifico/R&S | 06/11/2020 |
| LARIMAR THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 05/03/2019 |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2012 |
Formazione di Dennis D. Kim
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
82
Relazioni di 1° grado
16
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 16 |
|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
Orexigen Therapeutics, Inc.
 Orexigen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on the treatment of obesity | Health Technology |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
Cebix, Inc.
 Cebix, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for complications of diabetes | Health Technology |
Finch University of Health Sciences
 Finch University of Health Sciences Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
EnteroMedics, Inc.
 EnteroMedics, Inc. Medical SpecialtiesHealth Technology Develops medical devices to treat obesity and gastrointestinal disorders | Health Technology |
Rady School of Management at UC San Diego
 Rady School of Management at UC San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chicago Medical School
 Chicago Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skye Bioscience, Inc.
 Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Emerald Health Sciences, Inc.
 Emerald Health Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops cannabinoid pharmaceutical drugs | Health Technology |
AFYX Therapeutics AS
 AFYX Therapeutics AS Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Xeno Biosciences, Inc.
Xeno Biosciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company pioneering a novel class of treatments for metabolic diseases | Health Technology |
Inversago Pharma, Inc.
Inversago Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops CB1 receptor based therapies for obesity, diabetes and complication treatment | Health Technology |
